Mechanism for substance P-induced activation of human neutrophils and eosinophils.
Iwamoto
I
I
Second Department of Internal Medicine, Chiba University School of Medicine, Japan.
Nakagawa
N
N
Yamazaki
H
H
Kimura
A
A
Tomioka
H
H
Yoshida
S
S
D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004804:Eosinophils / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D010446:Peptide Fragments / Q000494:pharmacology; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D013373:Substance P / Q000494:pharmacology*; D013481:Superoxides / Q000097:blood
D010446:Peptide Fragments; D013481:Superoxides; D013373:Substance P; C032292:substance P (6-11); C032682:substance P (4-11); D011761:Pyrrolidonecarboxylic Acid